FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Began commercial use of its hospital AI ECG monitoring with a first hospital supply.

  • Supplied its AI telemetry solution to a hospital for about 100 beds. Source

Roles often seen at this stageDevice R&D & support · Sales & marketing · Data & AI

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

HUINNO

A maker of wearable ECG devices and an AI telemetry solution for remote ECG monitoring in hospitals.

MEMO Q

Marketed

AI telemetry solution that remotely watches ward patients' ECG, now supplied to hospitals with a pharmaceutical partner.

MEMO Patch M

Approved

Wearable ECG recorder measuring for up to eight days, cleared under US FDA 510(k).

Completion reported

Began commercial use of its AI telemetry solution with a first hospital supply.

Official role guide

HUINNO careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 유한양행-휴이노, AI 텔레메트리 솔루션 '메모큐' 공급…상용화 본격화 ↗아주경제 · Published 2026-04-21 · Sources checked 2026-11-15 · Original unavailable
  2. 휴이노, 웨어러블 심전도 측정 '메모 패치 M' FDA 승인 획득 ↗라포르시안 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable